Immuron Board Changes - Immuron (NASDAQ:IMRN)

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his

Related Keywords

Australia ,Canada ,United Kingdom ,United States ,Melbourne ,Victoria ,Australian ,American ,Jeannie Joughin ,Steven Lydeamore ,Flagellin Sears ,Paul Brennan ,Roger Aston ,Securities Exchange ,Bristol Myers Squibb ,Immuron Limited ,Immuron Platform Technology ,Non Executive Director ,Non Executive Chairman ,Australian Register ,Therapeutic Goods ,Opin Infect ,Scandinavian Journal ,Tropical Medicine ,Immune Components ,Anti Diarrheagenic Enterotoxigenic Escherichia ,Hyperimmune Bovine Colostrum ,Immuron News ,Securities Act ,Securities Exchange Act ,